Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin in the ARISTOTLE Trial: Predictors, Characteristics, and Clinical Outcomes

Study Questions:

What are the clinical characteristics of patients treated with apixaban for stroke prevention in atrial fibrillation (AF), who experienced major bleeding events?